$9.8
3M Ago | 1M Ago | Current | |
Buy | 8 | 8 | 8 |
Outperform | 5 | 5 | 5 |
Hold | 4 | 4 | 4 |
Underperform | 0 | 0 | 0 |
Sell | 0 | 0 | 0 |
The latest share price target for Amicus Therapeutics, Inc. (FOLD) is $17.33, offered by 17 analysts offering 12-month price forecasts.
Amicus Therapeutics, Inc. (FOLD) has a maximum of 0.77 upside potential, based on 17 analysts offering 12-month price forecasts.
Based on 17 analysts tracking and researching Amicus Therapeutics, Inc. (FOLD), 76.47% have a buy recommendation. Remaining 23.53% have either sell or hold recommendations.
The latest share price of Amicus Therapeutics, Inc. (FOLD) is $9.8 as of 02/06/2024.
13 of total 17 analysts offering stock ratings for Amicus Therapeutics, Inc. FOLD have recommended buy rating.